In 2022, the combined research and development (R&D) expenditure of the U.S. pharmaceutical industry consisted of more than $100 billion. While this is a significantly expansive market, approximately ...

invoX Pharma Limited (“invoX”), a research-driven global biopharmaceutical company with an advancing pipeline of innovative products, and Insilico Medicine (“Insilico”), a leading and global clinical ...

What are the top ten companies that academics go to when taking a research position in the private sector? There are a lot to choose from. The world of commercial research and development (R&D) spans ...

Forbes contributors publish independent expert analyses and insights. Kathleen Walch covers AI, ML, and big data best practices. The pharmaceutical industry, known for its rigorous research, complex ...

INGELHEIM, Germany & SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Boehringer Ingelheim and Circle Pharma (Circle) announce a new research collaboration and license agreement with the shared goal to ...

Deloitte attributed rising R&D costs to increases in trial times, complex research areas, economic factors, tech advancements and high attrition rates. (iStock / Getty Images Plus) The average cost ...

Silo Pharma, Inc., a biopharmaceutical company focused on developing innovative treatments for mental health and chronic pain, announced in a recent letter to shareholders that it expects to submit an ...

Pharmaceutical giant Novartis is shutting down a San Diego facility as part of a broader restructuring of the company’s drug development segment. In the first phase of layoffs, the Basel, ...